Xcout Intel
Axiom Bio
Axiom Bio is a biotechnology company that develops AI-driven predictive models and translational intelligence tools to assess drug toxicity and minimize clinical trial failures in drug discovery.
Subscribe to see Axiom Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Axiom Bio at a glance
Axiom Bio is a biotech company. Xcout tracks 6 named people at Axiom Bio, including Karen Markham (Chief Administrative Officer and Board Secretary). Xcout recorded 2 job postings from Axiom Bio in the last 90 days.
Axiom Bio leadership
- Karen MarkhamChief Administrative Officer and Board Secretary
- Luke PetersonChief Science Officer
- Remo Moomiaie-QajarFounder, CEO, and Chairman of the Board
- Yaming WangVP of China Operations
- Chris ThorneBoard Member
- Jaeyeol AnBoard Member
Hiring at Axiom Bio
Xcout recorded 2 job postings from Axiom Bio in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Axiom Bio's hiring signals →
Tech stack
Axiom Bio competitors
A few of Axiom Bio's closest competitors — see the full list of competitors and alternatives →
Avicenna Biosciences, Inc. is a biotechnology company that uses machine learning-enhanced medicinal chemistry to accelerate drug discovery and optimization.
CytoReason provides a computational disease modeling platform designed for pharmaceutical R&D. The company's technology uses human data to help scientists and executives map disease mechanisms, prioritize drug portfolios, and predict treatment performance.
Aikium is a biotechnology company headquartered in Berkeley, California, that integrates deep learning with ultra-large-scale wet lab experimentation to advance protein therapeutics.
1910 Genetics is a biotechnology company that integrates artificial intelligence with biology to accelerate drug discovery. Their mission is to reduce the timeline and cost of developing treatments for genetic diseases.
Atomic AI is a biotechnology research company specializing in RNA drug discovery utilizing atomic precision. Headquartered in San Francisco, California, the company combines machine learning and biology to develop advanced therapeutics.
Get Axiom Bio's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Axiom Bio? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Axiom Bio in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access